TECHNE CORP /MN/·4

Aug 1, 10:14 AM ET

VERONNEAU MARCEL 4

4 · TECHNE CORP /MN/ · Filed Aug 1, 2012

Insider Transaction Report

Form 4
Period: 2012-07-27
VERONNEAU MARCEL
VP-Hematology Operations
Transactions
  • Award

    Stock Option

    2012-07-27+1,0971,097 total
    Exercise: $74.05From: 2012-07-27Exp: 2019-07-26Common Stock (1,097 underlying)
Holdings
  • Stock Option

    Exercise: $56.83From: 2007-07-27Exp: 2014-07-26Common Stock (510 underlying)
    510
  • Stock Option

    Exercise: $76.15From: 2011-07-28Exp: 2018-07-27Common Stock (1,129 underlying)
    1,129
  • Stock Option

    Exercise: $66.25From: 2012-04-30Exp: 2017-04-29Common Stock (10,000 underlying)
    10,000
  • Stock Option

    Exercise: $51.60From: 2005-08-18Exp: 2012-08-17Common Stock (475 underlying)
    475
  • Common Stock

    34,569
  • Stock Option

    Exercise: $76.15From: 2012-06-30Exp: 2018-07-27Common Stock (20,000 underlying)
    20,000
  • Stock Option

    Exercise: $62.46From: 2009-07-24Exp: 2016-07-23Common Stock (494 underlying)
    494
  • Stock Option

    Exercise: $49.43From: 2006-07-27Exp: 2013-07-26Common Stock (567 underlying)
    567
  • Common Stock

    (indirect: by Stock Bonus Plan)
    6,779
  • Stock Option

    Exercise: $58.40From: 2010-07-30Exp: 2017-07-29Common Stock (1,281 underlying)
    1,281
  • Stock Option

    Exercise: $79.41From: 2008-07-25Exp: 2015-07-24Common Stock (385 underlying)
    385
Footnotes (1)
  • [F1]Vested 5,000 each 6/30/12, 6/30/13, 6/30/14, 6/30/15

Documents

1 file
  • 4
    primary_doc.xmlPrimary

    PRIMARY DOCUMENT